000 | 01019 a2200265 4500 | ||
---|---|---|---|
005 | 20250515050440.0 | ||
264 | 0 | _c20070215 | |
008 | 200702s 0 0 eng d | ||
022 | _a1040-8746 | ||
024 | 7 |
_a10.1097/CCO.0b013e32801173ea _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBall, Douglas W | |
245 | 0 | 0 |
_aMedullary thyroid cancer: therapeutic targets and molecular markers. _h[electronic resource] |
260 |
_bCurrent opinion in oncology _cJan 2007 |
||
300 |
_a18-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 |
_aCarcinoma, Medullary _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 |
_aThyroid Neoplasms _xmetabolism |
773 | 0 |
_tCurrent opinion in oncology _gvol. 19 _gno. 1 _gp. 18-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/CCO.0b013e32801173ea _zAvailable from publisher's website |
999 |
_c16703636 _d16703636 |